PHOENIX – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”) announced that it has reached an agreement with the Massachusetts Cannabis Control Commission (CCC) to resolve all legacy regulatory issues related to its acquired Georgetown Mission facility.
“Once the Company understood the violations, we worked quickly to correct them and have implemented procedures to prevent them from happening again,” said Leo Gontmakher, CEO, 4Front Ventures. “We are happy to be through the process and appreciate the CCC’s diligence. Patients were protected and no one was harmed.”
Mr. Gontmakher continued, “We thank the Massachusetts Cannabis Control Commission for working together with us on resolving all outstanding issues. We have a common goal of putting the health and safety of Massachusetts patients first and we are excited to move forward to the final steps of the process to open for adult-use customers.”
About 4Front Ventures Corp.
4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries.
Headquartered in Phoenix, Arizona, 4Front has operations in Illinois, Massachusetts, California, Michigan and Washington state. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the entire cannabis value chain. For more information, visit 4Front’s website www.4frontventures.com
